These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 28682531)
1. Florida Best Practice Psychotherapeutic Medication Guidelines for Adults With Major Depressive Disorder. McIntyre RS; Suppes T; Tandon R; Ostacher M J Clin Psychiatry; 2017 Jun; 78(6):703-713. PubMed ID: 28682531 [TBL] [Abstract][Full Text] [Related]
2. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 1. Disease Burden and Principles of Care. Lam RW; McIntosh D; Wang J; Enns MW; Kolivakis T; Michalak EE; Sareen J; Song WY; Kennedy SH; MacQueen GM; Milev RV; Parikh SV; Ravindran AV; Can J Psychiatry; 2016 Sep; 61(9):510-23. PubMed ID: 27486151 [TBL] [Abstract][Full Text] [Related]
3. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments. Kennedy SH; Lam RW; McIntyre RS; Tourjman SV; Bhat V; Blier P; Hasnain M; Jollant F; Levitt AJ; MacQueen GM; McInerney SJ; McIntosh D; Milev RV; Müller DJ; Parikh SV; Pearson NL; Ravindran AV; Uher R; Can J Psychiatry; 2016 Sep; 61(9):540-60. PubMed ID: 27486148 [TBL] [Abstract][Full Text] [Related]
4. Florida Best Practice Psychotherapeutic Medication Guidelines for Adults With Bipolar Disorder: A Novel, Practical, Patient-Centered Guide for Clinicians. Ostacher MJ; Tandon R; Suppes T J Clin Psychiatry; 2016 Jul; 77(7):920-6. PubMed ID: 26580001 [TBL] [Abstract][Full Text] [Related]
5. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine Treatments. Ravindran AV; Balneaves LG; Faulkner G; Ortiz A; McIntosh D; Morehouse RL; Ravindran L; Yatham LN; Kennedy SH; Lam RW; MacQueen GM; Milev RV; Parikh SV; Can J Psychiatry; 2016 Sep; 61(9):576-87. PubMed ID: 27486153 [TBL] [Abstract][Full Text] [Related]
6. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 2. Psychological Treatments. Parikh SV; Quilty LC; Ravitz P; Rosenbluth M; Pavlova B; Grigoriadis S; Velyvis V; Kennedy SH; Lam RW; MacQueen GM; Milev RV; Ravindran AV; Uher R; Can J Psychiatry; 2016 Sep; 61(9):524-39. PubMed ID: 27486150 [TBL] [Abstract][Full Text] [Related]
7. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials. Iovieno N; Tedeschini E; Bentley KH; Evins AE; Papakostas GI J Clin Psychiatry; 2011 Aug; 72(8):1144-51. PubMed ID: 21536001 [TBL] [Abstract][Full Text] [Related]
8. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication. Parikh SV; Segal ZV; Grigoriadis S; Ravindran AV; Kennedy SH; Lam RW; Patten SB; J Affect Disord; 2009 Oct; 117 Suppl 1():S15-25. PubMed ID: 19682749 [TBL] [Abstract][Full Text] [Related]
9. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments. Milev RV; Giacobbe P; Kennedy SH; Blumberger DM; Daskalakis ZJ; Downar J; Modirrousta M; Patry S; Vila-Rodriguez F; Lam RW; MacQueen GM; Parikh SV; Ravindran AV; Can J Psychiatry; 2016 Sep; 61(9):561-75. PubMed ID: 27486154 [TBL] [Abstract][Full Text] [Related]
10. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes. Lam RW; Kennedy SH; Adams C; Bahji A; Beaulieu S; Bhat V; Blier P; Blumberger DM; Brietzke E; Chakrabarty T; Do A; Frey BN; Giacobbe P; Gratzer D; Grigoriadis S; Habert J; Ishrat Husain M; Ismail Z; McGirr A; McIntyre RS; Michalak EE; Müller DJ; Parikh SV; Quilty LS; Ravindran AV; Ravindran N; Renaud J; Rosenblat JD; Samaan Z; Saraf G; Schade K; Schaffer A; Sinyor M; Soares CN; Swainson J; Taylor VH; Tourjman SV; Uher R; van Ameringen M; Vazquez G; Vigod S; Voineskos D; Yatham LN; Milev RV Can J Psychiatry; 2024 Sep; 69(9):641-687. PubMed ID: 38711351 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials. Tedeschini E; Levkovitz Y; Iovieno N; Ameral VE; Nelson JC; Papakostas GI J Clin Psychiatry; 2011 Dec; 72(12):1660-8. PubMed ID: 22244025 [TBL] [Abstract][Full Text] [Related]
12. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 6. Special Populations: Youth, Women, and the Elderly. MacQueen GM; Frey BN; Ismail Z; Jaworska N; Steiner M; Lieshout RJ; Kennedy SH; Lam RW; Milev RV; Parikh SV; Ravindran AV; Can J Psychiatry; 2016 Sep; 61(9):588-603. PubMed ID: 27486149 [TBL] [Abstract][Full Text] [Related]
13. Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants. Freeman MP; Mischoulon D; Tedeschini E; Goodness T; Cohen LS; Fava M; Papakostas GI J Clin Psychiatry; 2010 Jun; 71(6):682-8. PubMed ID: 20573327 [TBL] [Abstract][Full Text] [Related]
14. Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments. Kennedy SH; Lam RW; Cohen NL; Ravindran AV; Can J Psychiatry; 2001 Jun; 46 Suppl 1():38S-58S. PubMed ID: 11441771 [TBL] [Abstract][Full Text] [Related]
15. The prevalence, measurement, and treatment of the cognitive dimension/domain in major depressive disorder. McIntyre RS; Xiao HX; Syeda K; Vinberg M; Carvalho AF; Mansur RB; Maruschak N; Cha DS CNS Drugs; 2015 Jul; 29(7):577-89. PubMed ID: 26290264 [TBL] [Abstract][Full Text] [Related]
16. Major depressive disorder in breast cancer: a critical systematic review of pharmacological and psychotherapeutic clinical trials. Carvalho AF; Hyphantis T; Sales PM; Soeiro-de-Souza MG; Macêdo DS; Cha DS; McIntyre RS; Pavlidis N Cancer Treat Rev; 2014 Apr; 40(3):349-55. PubMed ID: 24084477 [TBL] [Abstract][Full Text] [Related]
17. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy. Akiskal HS; Benazzi F; Perugi G; Rihmer Z J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694 [TBL] [Abstract][Full Text] [Related]
18. Major depressive disorder treatment guidelines in America and Europe. Davidson JR J Clin Psychiatry; 2010; 71 Suppl E1():e04. PubMed ID: 20371031 [TBL] [Abstract][Full Text] [Related]
19. Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. V. Complementary and alternative medicine treatments. Ravindran AV; Lam RW; Filteau MJ; Lespérance F; Kennedy SH; Parikh SV; Patten SB; J Affect Disord; 2009 Oct; 117 Suppl 1():S54-64. PubMed ID: 19666194 [TBL] [Abstract][Full Text] [Related]
20. Texas Children's Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder. Hughes CW; Emslie GJ; Crismon ML; Posner K; Birmaher B; Ryan N; Jensen P; Curry J; Vitiello B; Lopez M; Shon SP; Pliszka SR; Trivedi MH; J Am Acad Child Adolesc Psychiatry; 2007 Jun; 46(6):667-686. PubMed ID: 17513980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]